-
Notifications
You must be signed in to change notification settings - Fork 0
Research Model
What are the joint effects of performance and solution transparency on the innovation outcome?
- Solution transparency leads to convergence (Bodreau & Lakhani, 2014)
- The groups with performance transparency will have reference points that motivate them to jump and innovate if they are below the best. As a result, they will take more risks and explore more (Brunswicker & Prietula, 2017). Social aspiration will make people with performance information take more risks (March, 1988).
Level of analysis is done at the individual level.
- Innovation Performance
- novelty-phaseX -> novelty in phase X
- user-requirement-phaseX -> user requirement score in phase X
- infovis-phaseX -> information visualization score in phase X
- tech-phaseX -> technology score in phase X
- improve-novel-XY -> improvement in novelty score from phase X to phase Y
- improve-ur-XY -> improvement in user requirement score from phase X to phase Y
- improve-vis-XY -> improvement in information visualization score from phase X to phase Y
- improve-tech-XY -> improvement in technology score from phase X to phase Y
- improve-total-XY -> improvement in total score from phase X to phase Y
- Effort
- add-loc-XY -> lines of codes added from phase X to phase Y
- delete-loc-XY -> lines of codes deleted from phase X to phase Y
- change-files-XY -> number of files changes from phase X to phase Y
- improve-effort-XY -> improvement score calculated with 1*[number of lines added] - 0.5*[number of lines deleted]
- sum-add-loc -> sum of lines of codes added across all phases (phase12 + phase23 + phase34 + phase45)
- Exploration
3.1 Variety and Uniqueness
- Concept: Distance of search (Billinger et al. 2014; Brunswicker et. al. 2019; ). Cross stage similarity metrics on an individual level (Variable Name: individual_exploration (IND_EXP)). In addition, we will have template similarity (Variable Name: template_similarity (TEMP_SIM)).
- Concept: Relational Novelty (Kyriakou et al. 2021 ). Dissimilarity with others on a prior phase (Variable Name: stageX_bogotaX_high_similarity (stageX_bogotaX_high_similarity))
- Concept: Variety/Scope (Schiling et. al. 2011). Count of functions for each individual at each group and at each phase [ non-repetitive ] (Variable Name: unique functions for each individual without repetition (unique))
- Concept: Rareness measure (Schiling et. al. 2011; Uzzi et al. 2013). Rareness of functions (top 5%, 10%, 15%, 20% most unique functions pooled globally) (Variable Name: len_unique_bogotaX_phaseX)
- Attention
- phaseX-clicks-count -> clicks done by a person in a specific phase
- sum-clicks-count -> sum of clicks done by a person across all phases
- project-clicks-hacker -> number of clicks obtained by a particular hacker for his code for each person, each phase, each group
- project-clicks-count -> number of project clicks done by a particular person for each phase and each group.
- score-clicks-count -> number of score clicks done by a particular person for each phase and each group.
- cum-bogotaX-phaseX -> sum of the total scores of the projects clicked on by a particular user in a phase and in a group.
- unique_apps -> number of unique apps clicked on by a particular user in a phase and in a group ( removing repetition ).
Research Questions - What are the joint effects of performance and solution transparency on the innovation outcome?
- Innovation Performance
- Only the improve-novelty-15
- Compound Measure of improve-novelty-15, improve-tech-15, improve-ur-15, improve-vis-15 ( PCA / EFA )
- Compound Measure of improve-novelty-15, improve-ur-15 ( Ammabile - novel and useful )
- Effort
- added-loc-15 ( priority )
- effort-loc-15
- delete-loc-15
- Exploration
- New functions used, which are not used in the prior round.
- Visualization Components Used ( Yes / No )
- Error Rate
- Diff between stage 1 and stage 5 errors
- 4 treatments ( No Transparency, Performance Transparency, Solution Transparency, Full Transparency )
- 2 treatments recoded
H1 - Full transparency has the highest innovation performance compared to all the other treatment groups. H2 - Full transparency has the highest risk-taking behaviors compared to all the other treatment groups. H3 - Solution transparency H4 - The interactions of performance and solution transparency strengthen the effect of transparency independently.
- Motivations
- Aspirations ( measured with some kind of click measure + performance difference )
- Skills
- Prior Experience
- Attention ( measured with some kind of click measure )
Now, the ANOVA we want to do is to see whether the treatment has any impact on the performance such as 'improve-tech-15'. We also want to aspiration into account … technically making this an ANCOVA. We run the below commands to get the output.
library(car)
aov1 = aov( improve-tech-15 ~ treatment + aspiration, df)
Anova(aov1 ,type="III")
This yields the following result.
So we can see that treatment does influence improve-tech-15. But how exactly? Planned contrasts can help us find out more about this. However, planned contrasts require that we really understand our independent variable of interest.